Tumorigenesis induced by the HHV8-encoded chemokine receptor requires ligand modulation of high constitutive activity

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Tumorigenesis induced by the HHV8-encoded chemokine receptor requires ligand modulation of high constitutive activity. / Holst, P J; Rosenkilde, M M; Manfra, D; Chen, S C; Wiekowski, M T; Holst, B; Cifire, F; Lipp, M; Schwartz, T W; Lira, S A.

In: Journal of Clinical Investigation, Vol. 108, No. 12, 2001, p. 1789-96.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Holst, PJ, Rosenkilde, MM, Manfra, D, Chen, SC, Wiekowski, MT, Holst, B, Cifire, F, Lipp, M, Schwartz, TW & Lira, SA 2001, 'Tumorigenesis induced by the HHV8-encoded chemokine receptor requires ligand modulation of high constitutive activity', Journal of Clinical Investigation, vol. 108, no. 12, pp. 1789-96. https://doi.org/10.1172/JCI13622

APA

Holst, P. J., Rosenkilde, M. M., Manfra, D., Chen, S. C., Wiekowski, M. T., Holst, B., Cifire, F., Lipp, M., Schwartz, T. W., & Lira, S. A. (2001). Tumorigenesis induced by the HHV8-encoded chemokine receptor requires ligand modulation of high constitutive activity. Journal of Clinical Investigation, 108(12), 1789-96. https://doi.org/10.1172/JCI13622

Vancouver

Holst PJ, Rosenkilde MM, Manfra D, Chen SC, Wiekowski MT, Holst B et al. Tumorigenesis induced by the HHV8-encoded chemokine receptor requires ligand modulation of high constitutive activity. Journal of Clinical Investigation. 2001;108(12):1789-96. https://doi.org/10.1172/JCI13622

Author

Holst, P J ; Rosenkilde, M M ; Manfra, D ; Chen, S C ; Wiekowski, M T ; Holst, B ; Cifire, F ; Lipp, M ; Schwartz, T W ; Lira, S A. / Tumorigenesis induced by the HHV8-encoded chemokine receptor requires ligand modulation of high constitutive activity. In: Journal of Clinical Investigation. 2001 ; Vol. 108, No. 12. pp. 1789-96.

Bibtex

@article{4cd1df20fada11ddb219000ea68e967b,
title = "Tumorigenesis induced by the HHV8-encoded chemokine receptor requires ligand modulation of high constitutive activity",
abstract = "ORF74 (or KSHV-vGPCR) is a highly constitutively active G protein-coupled receptor encoded by HHV8 that is regulated both positively and negatively by endogenous chemokines. When expressed in transgenic mice, this chemokine receptor induces an angioproliferative disease closely resembling Kaposi sarcoma (KS). Here we demonstrate that several lines of mice carrying mutated receptors deficient in either constitutive activity or chemokine regulation fail to develop KS-like disease. In addition, animals expressing a receptor that preserves chemokine binding and constitutive activity but that does not respond to agonist stimulation have a much lower incidence of angiogenic lesions and tumors. These results indicate that induction of the KS-like disease in transgenic mice by ORF74 requires not only high constitutive signaling activity but also modulation of this activity by endogenous chemokines.",
author = "Holst, {P J} and Rosenkilde, {M M} and D Manfra and Chen, {S C} and Wiekowski, {M T} and B Holst and F Cifire and M Lipp and Schwartz, {T W} and Lira, {S A}",
note = "Keywords: Amino Acid Sequence; Animals; COS Cells; Chemokines; Ligands; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Transgenic; Molecular Sequence Data; Neovascularization, Pathologic; Receptors, Chemokine; Sarcoma, Kaposi; Signal Transduction; Viral Proteins",
year = "2001",
doi = "10.1172/JCI13622",
language = "English",
volume = "108",
pages = "1789--96",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "American Society for Clinical Investigation",
number = "12",

}

RIS

TY - JOUR

T1 - Tumorigenesis induced by the HHV8-encoded chemokine receptor requires ligand modulation of high constitutive activity

AU - Holst, P J

AU - Rosenkilde, M M

AU - Manfra, D

AU - Chen, S C

AU - Wiekowski, M T

AU - Holst, B

AU - Cifire, F

AU - Lipp, M

AU - Schwartz, T W

AU - Lira, S A

N1 - Keywords: Amino Acid Sequence; Animals; COS Cells; Chemokines; Ligands; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Transgenic; Molecular Sequence Data; Neovascularization, Pathologic; Receptors, Chemokine; Sarcoma, Kaposi; Signal Transduction; Viral Proteins

PY - 2001

Y1 - 2001

N2 - ORF74 (or KSHV-vGPCR) is a highly constitutively active G protein-coupled receptor encoded by HHV8 that is regulated both positively and negatively by endogenous chemokines. When expressed in transgenic mice, this chemokine receptor induces an angioproliferative disease closely resembling Kaposi sarcoma (KS). Here we demonstrate that several lines of mice carrying mutated receptors deficient in either constitutive activity or chemokine regulation fail to develop KS-like disease. In addition, animals expressing a receptor that preserves chemokine binding and constitutive activity but that does not respond to agonist stimulation have a much lower incidence of angiogenic lesions and tumors. These results indicate that induction of the KS-like disease in transgenic mice by ORF74 requires not only high constitutive signaling activity but also modulation of this activity by endogenous chemokines.

AB - ORF74 (or KSHV-vGPCR) is a highly constitutively active G protein-coupled receptor encoded by HHV8 that is regulated both positively and negatively by endogenous chemokines. When expressed in transgenic mice, this chemokine receptor induces an angioproliferative disease closely resembling Kaposi sarcoma (KS). Here we demonstrate that several lines of mice carrying mutated receptors deficient in either constitutive activity or chemokine regulation fail to develop KS-like disease. In addition, animals expressing a receptor that preserves chemokine binding and constitutive activity but that does not respond to agonist stimulation have a much lower incidence of angiogenic lesions and tumors. These results indicate that induction of the KS-like disease in transgenic mice by ORF74 requires not only high constitutive signaling activity but also modulation of this activity by endogenous chemokines.

U2 - 10.1172/JCI13622

DO - 10.1172/JCI13622

M3 - Journal article

C2 - 11748262

VL - 108

SP - 1789

EP - 1796

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 12

ER -

ID: 10536519